Copaxone Dry AMD Therapy Trial

Study Title

Weekly Vaccination with Copaxone as a Potential Therapy for Dry Age Related Macular Degeneration

Enrollment Status

This study is currently recruiting participants.


The purpose of this study is to evaluate how tolerable, safe, and effective it is to give Copaxone subcutaneous injections to adults with dry age related macular degeneration (Dry AMD).


Ages Eligible for Study: 50 years old and older

Genders Eligible for Study: Both

Inclusion Criteria

Contact Information

Dr. Richard Rosen, Retina Vitreous Specialist
Katy Tai, Research Manager or 212-979-4251


Home > Current Research > Clinical Trials in Ophthalmology > Copaxone Dry AMD Therapy Trial